Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study — Meletios A Dimopoulos (2015) | RDL Network
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Meletios A Dimopoulos, Hartmut Goldschmidt, Rubén Niesvizky, Douglas Joshua, Wee Joo Chng, Albert Oriol, Robert Z. Orlowski, Heinz Ludwig, Thierry Façon, Roman Hájek, Katja Weisel, Vânia Hungria, Leonard Minuk, Shibao Feng, Anita Zahlten‐Kumeli, Amy Kimball, Philippe Moreau
Hartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, Rubén Niesvizky, Wee Joo Chng, Douglas Joshua, Katja Weisel, Andrew Spencer, Robert Z. Orlowski, Shibao Feng, Karim Iskander, Meletios A Dimopoulos
Philippe Moreau, Meletios A Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kihyun Kım, Gracia Martínez, Chang‐Ki Min, Luděk Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, Marie‐Laure Risse, Gaëlle Asset, Sandrine Macé, Thomas G. Martin, Philippe Moreau, Meletios A Dimopoulos,
W-J Chng, Hartmut Goldschmidt, Meletios A Dimopoulos, Philippe Moreau, D. Joshua, Antonio Palumbo, Thierry Façon, H. Ludwig, Luděk Pour, Rubén Niesvizky, Albert Oriol, Laura Rosiñol, Aleksandr Suvorov, Gianluca Gaïdano, Tomáš Pika, Katja Weisel, Veselina Goranova‐Marinova, H. H. Gillenwater, Nehal Mohamed, Shibao Feng, Shyam Aggarwal, Roman Hájek
Paul G. Richardson, Albert Oriol, Meral Beksaç, Anna Marina Liberati, Mónica Galli, Fredrik Schjesvold, Jindriska Lindsay, Katja Weisel, Darrell White, Thierry Façon, Jesús F. San Miguel, Kazutaka Sunami, Peter O’Gorman, Pieter Sonneveld, Paweł Robak, С. В. Семочкин, Steve Schey, Xin Yu, Thomas Doerr, Amine Bensmaine, Tsvetan Biyukov, Teresa Peluso,
Discussion(0)
No comments yet. Be the first to comment.